Sam Brusco, Associate Editor08.02.22
ResMed has acquired Leipzig, Germany-based mementor, strengthening its sleep portfolio in Germany with a digital insomnia solution. The transaction’s financial terms were not disclosed.
mementor developed and owns the somnio digital insomnia therapy solution, Germany’s first and only permanently approved Digital Health Application (DiGA) in the sleep medicine fields.
Currently, only a small percentage of insomnia patients receive the cognitive behavioral therapy recommended in Germany’s S3 guideline. somnio is available as an “app on prescription” and its clinical effectiveness was demonstrated in two trials showing sustained improvement in sleep after two and twelve months.
“mementor is an ideal fit for ResMed Germany and, more important, millions of people across Germany who want to improve their sleep and overall health,” Katrin Pucknat, president at ResMed Germany told the press. “The founders have identified a large and neglected area of healthy sleep with an opportunity to help millions of people solve their chronic sleep issue with an easy-to-use digital at-home solution. We look forward to working with the team at mementor to help even more people in Germany achieve good, healthy sleep.”
mementor will be integrated as a separate business segment of ResMed in Germany and be a platform for further digital health developments. It will be co-led by mementor co-founder and CEO Do. Noah Lorenz and Katherina Jekerle, who was previously ResMed Germany’s senior marketing director.
“I am very much looking forward to working with the mementor team on further innovating digital solutions and helping more people suffering from insomnia with a digital therapy approach,” said Jekerle. “In doing so, we at ResMed Germany are committed to maintaining the start-up agility and creativity of the teams and support the brand as it continues to grow.”
“Joining forces with ResMed brings us a big step closer to our vision of helping people get a good and healthy night’s sleep,” said Lorenz. “I am excited to have found a perfect fit in ResMed, with whom we can work together to give more people access to somnio and develop further digital solutions. We look forward to joining the global ResMed family.”
mementor developed and owns the somnio digital insomnia therapy solution, Germany’s first and only permanently approved Digital Health Application (DiGA) in the sleep medicine fields.
Currently, only a small percentage of insomnia patients receive the cognitive behavioral therapy recommended in Germany’s S3 guideline. somnio is available as an “app on prescription” and its clinical effectiveness was demonstrated in two trials showing sustained improvement in sleep after two and twelve months.
“mementor is an ideal fit for ResMed Germany and, more important, millions of people across Germany who want to improve their sleep and overall health,” Katrin Pucknat, president at ResMed Germany told the press. “The founders have identified a large and neglected area of healthy sleep with an opportunity to help millions of people solve their chronic sleep issue with an easy-to-use digital at-home solution. We look forward to working with the team at mementor to help even more people in Germany achieve good, healthy sleep.”
mementor will be integrated as a separate business segment of ResMed in Germany and be a platform for further digital health developments. It will be co-led by mementor co-founder and CEO Do. Noah Lorenz and Katherina Jekerle, who was previously ResMed Germany’s senior marketing director.
“I am very much looking forward to working with the mementor team on further innovating digital solutions and helping more people suffering from insomnia with a digital therapy approach,” said Jekerle. “In doing so, we at ResMed Germany are committed to maintaining the start-up agility and creativity of the teams and support the brand as it continues to grow.”
“Joining forces with ResMed brings us a big step closer to our vision of helping people get a good and healthy night’s sleep,” said Lorenz. “I am excited to have found a perfect fit in ResMed, with whom we can work together to give more people access to somnio and develop further digital solutions. We look forward to joining the global ResMed family.”
